Rating History for OncoCyte Corp (OCX) by BTIG

More Stocks Rated by BTIG | Latest Ratings for OCX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/1/2022 Mark A. Massaro Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.47
(3.20)		 580.85% Details